Shenzhen Guozhong Venture Capital Management

Shenzhen Guozhong Venture Capital Management is an investment firm.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Shenzhen Guozhong Venture Capital Management Information

Geographic Data

Shenzhen Guozhong Venture Capital Management headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund(SHENZHEN)LLP with a size of 6 Billion Yuan. Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhen venture capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%).

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
2/2020 UISEE Series B -
8/2019 Newlinks Technology Series B 62.9M
5/2021 Beisen Series F 0
12/2017 Cosber Series A 1.5M
11/2022 SemiDrive Series B 138.7M
1/2020 Launca Medical Series B -
5/2022 DIGIBIRD Venture Round -
12/2017 ofpay Series A 3M
4/2018 chxsst.com Post-IPO Equity 10.6M
9/2019 SMARTBOW Series B 9.2M
8/2017 iKCRM Series A 3M
3/2020 Asieris Pharmaceuticals Series C 14.2M
1/2022 PhaBuilder Series A 39.4M
10/2022 Coreview Venture Round 14.1M
12/2021 HGC Lighting Solution Series B 20.4M
4/2022 HGC Lighting Solution Series B -
10/2022 Beihai Biotech Series B 27.6M
8/2019 Kangpu Biopharmaceuticals, Ltd. Series A 14M
8/2019 Safirst Technology Series E 14M
7/2017 XFinTech Seed Round 440.9k
3/2018 Hitomorrow Series A 15M
9/2019 Sanfu Interactive Entertainment Series A 4.2M
5/2019 Biotree Seed Round 1.5M
8/2019 Bio-Engine Series B -
11/2017 Ebusbar Series C 0
1/2023 Anshi New Energy Series B 44.3M
11/2017 Changzhou Wujin Zhongrui Electronics Series A 15M
12/2018 AIQI Technology Series B 14.5M
2/2020 Advaccine Venture Round 4.3M
7/2017 Slamtec Series B 22.1M
7/2019 Fourier Intelligence Series B -
1/2018 Huada Empyrean Software Corporate Round 15M
7/2016 Gritpharma Angel Round 0
12/2021 Chuangxin Huilian Technology Series C -
5/2019 Shanghai Biotree Seed Round 3M
5/2018 PVmed Series A -
11/2016 BOZWIN Series B 2.9M
12/2017 Unidiag Series A -
7/2018 Broadgnss Technologies Seed Round 3M
10/2018 Dayanse Technology Series A 14.4M
10/2019 Anbao Shangcheng Series B 1.4M
5/2018 Cipher Gene Tech Series A -
12/2018 Yoolook Series A 1.5M
12/2017 Sanhao.com Series B 0
12/2019 Remegen Private Equity Round -
8/2019 Baiwang Cloud Series B 70.5M
10/2017 Haoshou Bang Series A 15M
7/2016 Meten Series B 25.5M
7/2020 InnerMedical Series B -
9/2017 Seichitech Post-IPO Equity 3M
1/2018 Chance Pharmaceuticals Series A 8.4M
1/2022 Borui Jixin Series D -
12/2021 Meichuang Technology Series C 1B
5/2019 Little Bear Rental Series B -
12/2016 WinSing Animation Post-IPO Equity 0
3/2018 Bell.ai Series B -
6/2019 Yuanshan AI Series A -
7/2018 Barty Medical Series A 3M
8/2019 ELITE Technology Series B 14.2M
11/2017 1mdata.com Series B 15M
12/2017 Langying Jiaoyu Series A 3M
12/2021 DIAGENS Series B 15.7M
7/2021 Beihai Biotech Series A 15.5M
5/2017 AMT Series E 7.2M
1/2018 CalmCar Vision System Seed Round 4.6M
1/2022 Beihai Biotech Series A -
4/2019 Microtera Semiconductor Technologies Seed Round -
5/2017 EZFUN Series A 1.4M
10/2021 Chance Pharmaceuticals Series C 0
3/2018 Bell Robot &a; Coding Center Series B 15.8M
1/2018 ChengXing Shares Post-IPO Equity 15.4M
12/2017 KingFocus Biomedical Series A -
9/2017 Shenzhen 3-dragons Technology Co.,Ltd. Series A 6M
8/2016 Medcaptain Angel Round 450.6k
7/2017 Pregene Angel Round 3M
5/2020 Data Ground Series B 0
5/2022 DIGIBIRD Venture Round -
4/2022 HGC Lighting Solution Series B -
1/2022 Beihai Biotech Series A -
1/2022 Borui Jixin Series D -
12/2021 DIAGENS Series B 0
12/2021 HGC Lighting Solution Series B 0
12/2021 Meichuang Technology Series C 0
12/2021 Chuangxin Huilian Technology Series C -
10/2021 Chance Pharmaceuticals Series C 0
7/2021 Beihai Biotech Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research